STEMSATION(TM) EXPANDS CONSUMER REACH INTO $290 BILLION GLOBAL MARKET FOR NUTRACEUTICALS: Now Offering its Products in 30 Markets, in Four Currencies and Four Languages

BOCA RATON, FL / ACCESSWIRE / June 23, 2020 / StemSation International, Inc. (OTC PINK:STSN) – a pioneer in the emerging category of dietary supplements called Stem Cell Nutrition, announces its products are now available in 30 markets (the 27 EU markets, the UK, the US and Puerto Rico). The U.S. and European markets contribute $70 billion and $15 billion respectively to the $290 billion global market for nutraceuticals according to Fortune Business Insights.

The StemSation website is now providing its products in four languages (English, Spanish, French and Bulgarian) and four currencies (US dollar, British Pound, Euro and Bulgarian Lev). Our customer service staff is fluent in all four languages. The company is currently in process of adding more languages and currencies as it continues its worldwide expansion plans.

Ray C. Carter, Jr., CEO of StemSation stated “we are pleased that we are now able to offer our products in multiple markets, languages and currencies through our online platform, during our very first year of business. We plan to enter even more markets in the second half of 2020 while adding at least two more languages and currencies. Our investment in a global infrastructure and localized, consumer-friendly support will bring us many loyal, long-term customers over time in this fast-growing global market, projected to reach $486 billion by 2026.”

Stemsation is a company with a long-term ‘health mission’, ambitious research goals, and innovative, holistic approaches to health & wellness, and healthy longevity. Its product line shows a new pathway to wellness.


StemSation International, Inc. (OTC PINK:STSN) develops, manufactures and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body through using a direct selling model in which Independent Wellness Advocates (“IWAs”) advertise and sell its products directly to consumers. StemSation is headquartered in Boca Raton, Florida and its website can be located at


This press release contains forward-looking statements that can be identified by terminology such as “believes,” “expects,” “potential,” “plans,” “suggests,” “may,” “should,” “could,” “intends,” or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company’s control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Nicholas B. Panza, Vice-President
StemSation International, Inc.
7777 Glades Road
Suite 203
Boca Raton, FL 33434
(561) 245-7454

SOURCE: StemSation International, Inc.

View source version on

error: Content is protected !!